Stem cell transplants from matched donor sources have been the standard for more than 70 years but this article points out additional risks inherent in such grafts.
More research is necessary to provide alternatives such as expanded autologous cells instead of homologous transplants in order to avoid GVHR and other unknown disease transmission
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology